Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defesche

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
European Heart Journal|March 4, 2014
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcomeBarbara Sjouke, D Meeike Kusters, Iris Kindt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Journal of Atherosclerosis and Thrombosis|June 4, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summaryGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
European Journal of Preventive Cardiology|April 30, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
International Journal of Cardiology|January 15, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Human Mutation|October 13, 2018
ClinVar database of global familial hypercholesterolemia-associated DNA variantsMichael A Iacocca, Joana R Chora, Alain Carrié, et al.
Molecular and Cellular Probes|August 29, 2003
Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory elementC F Hoogendijk, C L Scholtz, S M Pimstone, et al.
Clinical Chemistry|November 22, 2014
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countriesMarta Futema, Sonia Shah, Jackie A Cooper, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
European Heart Journal|March 4, 2014
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcomeBarbara Sjouke, D Meeike Kusters, Iris Kindt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Journal of Atherosclerosis and Thrombosis|June 4, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summaryGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
European Journal of Preventive Cardiology|April 30, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
International Journal of Cardiology|January 15, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Human Mutation|October 13, 2018
ClinVar database of global familial hypercholesterolemia-associated DNA variantsMichael A Iacocca, Joana R Chora, Alain Carrié, et al.
Molecular and Cellular Probes|August 29, 2003
Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory elementC F Hoogendijk, C L Scholtz, S M Pimstone, et al.
Clinical Chemistry|November 22, 2014
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countriesMarta Futema, Sonia Shah, Jackie A Cooper, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
Pageof 18